Credit: Piotr Swat/ Shutterstock.com
November 28, 2019
Anglo-Swedish drugmaker AstraZeneca has announced this week that it is launching an initiative that will see the company invest in Israel’s growing digital health space.
Called BeyondBio, the scheme follows a memorandum of understanding for investment in Israel signed earlier this year by AstraZeneca and the Israel Innovation Authority.
According to a press statement, the first...
March 20, 2019
Belfast-based data analytics company Diaceutics announced yesterday that it will seek listing on London’s junior stock exchange, the Alternative Investment Market (AIM).
The firm, which serves the global pharmaceutical industry, plans to float on Thursday with an expected market capitalisation of around £53m ($70m).
Diaceutics said in a press release that it has already raised £17m ($22.5m)...
January 24, 2018
New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.
“We’ve had a great relationship over the last couple of years with AstraZeneca, we’ve launched in a couple dozen countries now...
August 17, 2016
IBM Watson Health announced that its Watson for Oncology program, trained at Memorial Sloan Kettering Hospital, will be rolled out to 21 hospitals throughout China. The initial 21-hospital introduction is the beginning of a multi-year partnership through which IBM's Chinese partner Hangzhou CognitiveCare will introduce Watson for Oncology to hospitals across China. More.
CareMore Health System ...
August 16, 2016
Pharmaceutical company AstraZeneca is beginning a clinical trial in collaboration with Quintiles looking at the impact of mobile medication reminders for people with chronic obstructive pulmonary disease (COPD).
The proposed yearlong trial – which is still not yet recruiting participants – will be an intervention study involving an estimated 380 people with COPD divided into two groups. Both...
July 5, 2016
In a deployment with UnitedHealthcare, health coaching startup Vida was able to reduce weight and blood pressure in a group of 1,000 high-BMI patients across three states, the company told MobiHealthNews.
"Over 58 percent of the population has seen weight loss and over 30 percent have lost more than 5 percent of their body weight, which is clinically significant," Vida CEO and Founder Stephanie...
June 16, 2016
Global pharmaceutical company AstraZeneca has launched a new patient-facing mobile app that includes a virtual savings card, a prescription tracker, and educational materials. The app, available in the US on the iOS App Store and Google Play store, is called AZhelps.
“AstraZeneca is committed to providing affordable medicines and programs that help patients get the support they need," Lori...
December 7, 2015
French companion app company Voluntis has partnered with AstraZeneca to develop an app for women undergoing treatment for ovarian cancer. Specifically, the app will help patients and clinicians manage the side effects of a combination therapy of the drugs cediranib and olaparib, which can cause hypertension and diarrhea.
"AstraZeneca has a strong focus on the use of companion devices in drug...
November 3, 2015
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way. Two acquisitions, a $3 million investment, and a number of pilot and partnership deals have shown clearly that the space is of interest. (MobiHealthNews is helping to put on two pharma-related events at the mHealth Summit next week -- be sure to join us if you'll be in...
October 8, 2015
Propeller Health is working with Boehringer Ingelheim.
Pharma's investment in the digital health space is getting more and more real and substantive as companies move beyond the pilot stage and start to launch real digital health interventions, from Teva buying up smart inhaler company Gecko to Otsuka gearing up to launch a commercial drug integrated with a Proteus sensor.